Skip to main content
JHS Svendgaard Laboratories Ltd. logo

JHS Svendgaard Laboratories Ltd. — Investor Relations & Filings

Ticker · JHS ISIN · INE544H01014 LEI · 335800NYNAOOMRTTWW75 BSE.NS Manufacturing
Open in API
Filings indexed 678 across all filing types
Latest filing 2025-05-21 Regulatory Filings
Country IN India
Listing BSE.NS JHS

About JHS Svendgaard Laboratories Ltd.

https://www.svendgaard.com/

JHS Svendgaard Laboratories Ltd. is a specialized manufacturer of oral care products, operating primarily through contract manufacturing and private labeling arrangements. The company provides end-to-end solutions for oral hygiene, including the production of toothbrushes, toothpastes, mouthwashes, and specialized dental care items. It maintains large-scale manufacturing facilities equipped to handle high-volume production for global and domestic FMCG brands. In addition to its business-to-business operations, the company manages its own consumer brand, Aquawhite, which focuses on innovative oral care solutions for various age groups, including a significant range of licensed character-based products for children. The organization emphasizes quality control and technical expertise in oral health product development, catering to diverse market segments through a robust supply chain and distribution network.

Recent filings

Filing Released Lang Actions
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-05-21 English
General Updates
Capital/Financing Update Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the outcome of a Board of Directors meeting held on May 17, 2025. It details the Board's resolution to amend the objects for utilization of proceeds from a previously approved Preferential Issue. The content focuses on changes in the use of funds raised through a capital raising event, specifying revised financial allocations and timelines. There is no presentation of financial statements, audit opinions, or detailed financial performance data. The document is not a full report but an announcement of a Board decision related to capital utilization. This fits the category of Capital/Financing Update (CAP), as it updates on the company's financing activities and capital structure changes. The document length is 4302 characters, which is sufficient for a detailed announcement but not a full report. Therefore, the appropriate classification is CAP with high confidence.
2025-05-17 English
Outcome of Board Meeting
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the deferment of the agenda item related to the approval of Audited Financial Results for the quarter and year ended 31st March 2025. It references SEBI regulations and informs about the postponement of the Board Meeting to approve these results. The document does not contain any financial data or the actual financial results but is an announcement about the deferment of the approval of such results. The document length is 3174 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about a corporate event (deferment of financial results approval) and does not contain the financial report itself.
2025-05-17 English
Board Meeting — Financial Results
Board/Management Information Classification · 95% confidence The document is a formal notice addressed to stock exchanges regarding an upcoming Board of Directors meeting scheduled for May 17, 2025. The purpose of the meeting is to consider and approve the audited financial results for the quarter and year ended March 31, 2025. The document also mentions the closure of the trading window in compliance with insider trading regulations. The document is short (1781 characters) and serves as an intimation or announcement about the meeting and forthcoming financial results, not the financial results report itself. It does not contain any financial data or detailed analysis. Therefore, it is an announcement related to a board meeting and financial results approval, fitting the category of Board/Management Information (MANG).
2025-05-12 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-05-12 English
Outcome of Board Meeting
Board/Management Information Classification · 100% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) regarding compliance under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It announces the outcome of a Board Meeting held on April 29, 2025, specifically the re-appointment of two Independent Directors, subject to shareholder approval. The document includes detailed disclosures about the directors as required under Regulation 30 and SEBI circulars. There is no financial data, earnings information, or report attached; rather, it is an announcement of board/management changes. Therefore, the document fits the category of Board/Management Information (MANG). The document length (6252 characters) and content confirm it is not a brief announcement or a report publication notice but a substantive announcement of management changes.
2025-04-29 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.